Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5025,387.40.97%H 25,501.35 · L 25,267.3upd. 17 Nov, 3:31 PM IST|Sensex82,532.191.15%H 82,897.49 · L 82,091.9upd. 17 Nov, 3:32 PM IST|Bank Nifty62,273.252.03%H 62,442.2 · L 61,488upd. 17 Nov, 3:31 PM IST|USD / INR₹93.460.48%H ₹93.92 · L ₹93.38as of 17 Nov, 7:17 PM IST|Gold Intl (10g)₹1,16,222.910.39%H ₹1,17,007.17 · L ₹1,15,360.53as of 17 Nov, 11:14 PM IST|Silver Intl (1kg)₹1,42,653.191.31%H ₹1,43,990.33 · L ₹1,40,489.73as of 17 Nov, 11:14 PM IST|Crude WTI₹8,083.360.9%H ₹8,166.53 · L ₹7,914.19as of 17 Nov, 11:14 PM IST|Bitcoin₹59,70,7302.19%H ₹60,36,106.1 · L ₹59,05,353.9as of 17 Nov, 10:54 PM IST|Ethereum₹1,66,9722.89%H ₹1,69,384.49 · L ₹1,64,559.51as of 17 Nov, 10:54 PM IST|Nifty 5025,387.40.97%H 25,501.35 · L 25,267.3upd. 17 Nov, 3:31 PM IST|Sensex82,532.191.15%H 82,897.49 · L 82,091.9upd. 17 Nov, 3:32 PM IST|Bank Nifty62,273.252.03%H 62,442.2 · L 61,488upd. 17 Nov, 3:31 PM IST|USD / INR₹93.460.48%H ₹93.92 · L ₹93.38as of 17 Nov, 7:17 PM IST|Gold Intl (10g)₹1,16,222.910.39%H ₹1,17,007.17 · L ₹1,15,360.53as of 17 Nov, 11:14 PM IST|Silver Intl (1kg)₹1,42,653.191.31%H ₹1,43,990.33 · L ₹1,40,489.73as of 17 Nov, 11:14 PM IST|Crude WTI₹8,083.360.9%H ₹8,166.53 · L ₹7,914.19as of 17 Nov, 11:14 PM IST|Bitcoin₹59,70,7302.19%H ₹60,36,106.1 · L ₹59,05,353.9as of 17 Nov, 10:54 PM IST|Ethereum₹1,66,9722.89%H ₹1,69,384.49 · L ₹1,64,559.51as of 17 Nov, 10:54 PM IST|
0%
Stock Market

Indoco Remedies Shares Surge 13% on Profitability Turnaround; Analysts Eye ₹288 Target

Arth Vani DeskPublished: 1 min read
Indoco Remedies Shares Surge 13% on Profitability Turnaround; Analysts Eye ₹288 Target

Source: Mint Markets

Arth Insight · What this means for your wallet

Immediate action
Research Indoco Remedies' financials and analyst reports if you are considering pharmaceutical sector investments.
  • If you hold Indoco Remedies shares, your investment value has likely increased significantly (over 13% in a week).
  • For new investors, this flags a pharmaceutical stock with improved profitability and analyst-projected upside towards ₹288.
  • It demonstrates how a company's financial turnaround can directly boost your investment's potential returns, or signal an entry point.
Recommended for you
Track live indices, stocks & movers
Open Markets
Listen to this article
AI voice · Podcast mode
Get IPO & market alerts free on Telegram / WhatsApp
AI Summary

Shares of Indoco Remedies witnessed a significant jump of 13.21% in a week, driven by improved technical indicators and a return to quarterly profitability. Market analysts have identified key resistance levels for the stock, with a potential breakout opening the path towards ₹280-₹288.

Key Highlights
  • ▸Indoco Remedies shares surged 13.21% in a week, driven by profitability and technical momentum.
  • ▸Analysts identify ₹256-₹260 as a key resistance level for the stock.
  • ▸Strong support for the shares is seen around ₹230-₹235.
  • ▸A breakout above resistance could lead the stock towards ₹280-₹288.
Key Takeaways
  • ✓Indoco Remedies shares surged 13.21% in a week, driven by profitability and technical momentum.
  • ✓Analysts identify ₹256-₹260 as a key resistance level for the stock.
  • ✓Strong support for the shares is seen around ₹230-₹235.
  • ✓A breakout above resistance could lead the stock towards ₹280-₹288.

Indoco Remedies, a prominent pharmaceutical company, saw its shares climb by 13.21% over the past week, signaling renewed investor interest. This notable surge is attributed to two primary factors: the company's return to profitability in its recent quarterly results and strengthening technical momentum observed in its stock charts.

The positive sentiment surrounding Indoco Remedies marks a shift, as the stock had previously been navigating challenges. A return to consistent profitability is often a strong signal for investors, indicating improved financial health and operational efficiency.

Analyst Outlook: Key Levels to Watch

Market analysts are closely monitoring the stock's performance and have outlined critical technical levels that could influence its future trajectory. According to their assessments, Indoco Remedies shares are currently facing resistance in the range of ₹256 to ₹260. Overcoming this resistance zone would be a significant indicator of further upward momentum.

Conversely, analysts have pinpointed strong support for the stock around the ₹230 to ₹235 levels. This support zone is where buying interest is expected to emerge, potentially preventing further declines in share price. For investors, these support levels can serve as crucial indicators of potential entry points or areas where the stock might stabilize.

Should Indoco Remedies successfully break through the aforementioned resistance zone of ₹256-₹260, market experts suggest that the stock could pave the way for a rally towards the ₹280 to ₹288 range. Such a move would represent a substantial gain for shareholders and reflect continued positive market sentiment.

The recent price action, combined with the company's improved financials, positions Indoco Remedies as a stock to watch for investors interested in the pharmaceutical sector. However, like all investments, it is subject to market risks and broader economic factors.

This report is for informational purposes only and does not constitute financial or investment advice. Investors should conduct their own research or consult a financial advisor.

Recommended for you
Products related to this story — compare & act
Smart picks
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
13.5%
3Y CAGR
Bharat Mobility IPO
Mainboard · Auto
+20.5%
GMP
View IPO
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
12.8%
3Y CAGR
GreenVolt Energy IPO
Mainboard · Renewables
+13.8%
GMP
View IPO
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
12.7%
3Y CAGR
Axis ELSS- Tax Saver Fund
Axis Mutual Fund · ELSS
12.2%
3Y CAGR

Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.

Frequently Asked Questions

Why did Indoco Remedies shares jump recently?

Indoco Remedies shares jumped 13.21% in a week primarily due to the company returning to quarterly profitability and improving technical momentum observed in its stock charts.

What are the key resistance and support levels for Indoco Remedies stock?

Analysts have identified resistance for Indoco Remedies shares between ₹256 and ₹260, while strong support is seen around the ₹230 to ₹235 levels.

What is the potential upside for Indoco Remedies shares according to analysts?

If Indoco Remedies shares successfully break through the resistance level of ₹256-₹260, analysts suggest the stock could potentially rally towards the ₹280 to ₹288 range.

Stay ahead of the market

Join the Arth Vani channels

Daily news summaries, IPO & market alerts on Telegram and WhatsApp.

Related Stories

Advanced Sys-Tek Gets Sebi Nod for IPO; Fund Utilisation Details Emerge
IPOBreaking
Stock Market

Advanced Sys-Tek Gets Sebi Nod for IPO; Fund Utilisation Details Emerge

Market regulator SEBI has approved Advanced Sys-Tek's initial public offering (IPO), allowing the company to proceed with its fundraising plans. The fresh issue proceeds are earmarked for financing expansion and meeting long-term working capital requirements. Key details like the IPO price band and issue dates are still awaited.

7h ago·1 min readListen
Univest Predicts Nifty at 25,387 for November 18
Breaking
Stock Market

Univest Predicts Nifty at 25,387 for November 18

Financial firm Univest has issued a stock market prediction, projecting the Nifty 50 index to reach 25,387 levels for November 18. While a specific Nifty target is mentioned, the underlying analysis or other detailed levels for the day were not immediately available in the provided source.

7h ago·1 min readListen
Urban Company’s ₹2,500 Crore QIP Oversubscribed 6 Times; Bids Hit ₹15,300 Crore
IPOBreaking
Stock Market

Urban Company’s ₹2,500 Crore QIP Oversubscribed 6 Times; Bids Hit ₹15,300 Crore

Home services platform Urban Company has reportedly received a massive response for its ₹2,500-crore Qualified Institutional Placement (QIP). The issue was oversubscribed six times, attracting bids worth ₹15,300 crore from global and domestic institutional investors.

17h ago·1 min readListen
Indian Markets Anticipate Subdued Open on November 17, 2020; Key Stocks in Focus
Stock Market

Indian Markets Anticipate Subdued Open on November 17, 2020; Key Stocks in Focus

Indian equity markets were poised for a subdued opening on Tuesday, November 17, 2020, influenced by weak global trends, despite a previous session's rally. Investors were advised to watch a selection of specific stocks, including Senco Gold, Adani Enterprises, BSE, and Cipla, for potential market movements.

1d ago·1 min readListen